Sol-Gel Technologies News and Activities

Sol-Gel Technologies is a company listed under the stock ticker SLGL (IL).

View the org chart displaying its 15 main executives

Most searched biographies at Sol-Gel Technologies

• Mori Arkin, Chief Executive Officer and Chairman of the Board
• Sharon Kochan, Director
• Hani Lerman, Director

Create your alert
to follow the executive moves at Sol-Gel Technologies.

Sol-Gel Technologies has 2,417 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Zymeworks has announced the acquisition of Theravance Biopharma  (posted on June 29 2026).
• Tissium has just announced a $68 Million fundraising (posted on June 29 2026).
• Oblenio Bio has just announced a $62 Million fundraising (posted on June 26 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Sol-Gel Technologies

• Press Releases | Sol-Gel
• Press Releases | Sol-Gel
• Press Releases | Sol-Gel
• Press Releases | Sol-Gel
• Press Releases | Sol-Gel
• Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study | Sol-Gel
• Press Releases | Sol-Gel
• Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610 | Sol-Gel
• Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Sol-Gel
• Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference | Sol-Gel
• View more press releases Close

Social media about Sol-Gel Technologies

• Sol-Gel Technologies on Wikipedia, Google News & Yahoo Finance
• Sol-Gel Technologies on LinkedIn, X (Twitter) & YouTube